Upcoming Shows & Events

NanoString at CRUK Cambridge Institute

Small Sample, Big Insight. NanoString solutions from gene expression, to Digital Spatial Profiling and Hyb & Seq

SPEAKER: Agenda will be published shortly
DATE:

May 11, 2018

10:00 to 13:30 (GMT) - Lunch will be served.
LOCATION: CRUK Cambridge Institute- University of Cambridge
Li Ka Shing Centre- Robinson Way
Cambridge CB2 0RE

Agenda:

KRAS induces lung tumorigenesis via microRNAs modulation

Dr. Michael Garofalo, PhD | Transcriptional Networks in Lung Cancer Research Leader, Cancer Research UK Manchester

Tumor inflammation signature predicts clinical benefit of antiPD1 therapy in CERTIM multi-cancer cohort

Professor Karen Leroy, MD, PhD | Professor in Molecular Oncology, University Paris Descartes, PARIS Genetics and Molecular Biology department, HUPC COCHIN PARIS, AP-HP. INSERM U1016, Institut Cochin - Paris

Hyb & Seq™ Technology: A no amp, no library, single molecule sequencer designed for future clinical applications

Michael Rhodes, PhD | Senior Director Advanced Sequencing Applications, Nanostring Technologies, Inc. 

Simultaneous mutation detection, copy number identification and gene expression profiling of ovarian cancer using Hyb & Seq™ targets sequencing techology 

Dr. Anna Piskorz | Senior Research Associate, Functional Genomics and Ovarian Cancer Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge

Digital Spatial Profiling of bone marrow-infiltrating immune cells in acute myeloid leukemia

Prof. Sergio Rutella, MD, PhD | Professor of Cancer Immunotherapy John van Geest Cancer Research Centre Nottingham Trent University - United Kingdom

Cambridge.png       CRUK.png